Literature DB >> 23903698

Role of coagulation in the recruitment of colon adenocarcinoma cells to thrombus under shear.

Sandra M Baker-Groberg1, Asako Itakura, András Gruber, Owen J T McCarty.   

Abstract

Colorectal cancer metastases can appear on the peritoneum and in lymph nodes, liver, and lungs, suggesting both hematogenous and lymphatic spreading of the primary tumor. While antithrombotic agents have been shown to reduce both long-term incidence and metastasis, the role of coagulation in facilitating metastasis is ill defined. We investigated the kinetics and molecular mechanisms of metastatic colon adenocarcinoma cell recruitment to thrombi under shear flow, ex vivo. Platelet aggregates were formed by perfusing citrated anticoagulated whole blood over immobilized fibrinogen or fibrillar collagen. Thrombi were formed by perfusing recalcified whole blood over fibrinogen or fibrillar collagen in the presence of coagulation. Cultured colon adenocarcinoma cells (SW620) were perfused either during or following platelet aggregate or thrombus formation. The degree of transient tumor cell interactions (recruitment, rolling, and release) and the number of firmly adhered tumor cells were quantified using fluorescence microscopy. Platelet aggregates and thrombi formed on either fibrinogen- or fibrillar-collagen supported SW620 cell interactions and adhesion under shear. Thrombi or fibrin supported a greater degree of SW620 cell interactions and adhesion compared with platelet aggregates or fibrinogen, respectively, demonstrating that coagulation promoted SW620 cell recruitment under shear. Interestingly, in the absence of anticoagulation, we observed SW620 preferentially binding to thrombus-bound polymorphonuclear leukocytes (PMNs). The addition of purified PMNs to thrombi resulted in a doubling of the number of interacting and bound SW620 cells. Since thrombi often accumulate and activate leukocytes, our findings suggest that leukocytes may play a role in localizing metastases to sites of thrombogenesis.

Entities:  

Keywords:  cancer metastasis; coagulation; inflammation; leukocytes; thrombosis

Mesh:

Year:  2013        PMID: 23903698      PMCID: PMC4042537          DOI: 10.1152/ajpcell.00185.2013

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  79 in total

1.  Systemic coagulation reactivation in recurrence of colorectal cancer.

Authors:  Lene H Iversen; Ole Thorlacius-Ussing
Journal:  Thromb Haemost       Date:  2003-04       Impact factor: 5.249

2.  Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation.

Authors:  Jae Hong Im; Weili Fu; Hui Wang; Sujata K Bhatia; Daniel A Hammer; M Anna Kowalska; Ruth J Muschel
Journal:  Cancer Res       Date:  2004-12-01       Impact factor: 12.701

3.  Capillary blood viscosity in microcirculation.

Authors:  A Cortinovis; A Crippa; R Cavalli; M Corti; L Cattaneo
Journal:  Clin Hemorheol Microcirc       Date:  2006       Impact factor: 2.375

4.  Human neutrophils facilitate tumor cell transendothelial migration.

Authors:  Q D Wu; J H Wang; C Condron; D Bouchier-Hayes; H P Redmond
Journal:  Am J Physiol Cell Physiol       Date:  2001-04       Impact factor: 4.249

5.  The role of polymorphonuclear leukocytes (PMN) on the growth and metastatic potential of 13762NF mammary adenocarcinoma cells.

Authors:  P A Aeed; M Nakajima; D R Welch
Journal:  Int J Cancer       Date:  1988-11-15       Impact factor: 7.396

6.  Isolation and characterization of antistasin. An inhibitor of metastasis and coagulation.

Authors:  G P Tuszynski; T B Gasic; G J Gasic
Journal:  J Biol Chem       Date:  1987-07-15       Impact factor: 5.157

7.  Excess leukocytosis (leukemoid reactions) associated with malignant diseases.

Authors:  L C McKee
Journal:  South Med J       Date:  1985-12       Impact factor: 0.954

8.  Influence of migratory blood cells on the attachment of tumor cells to vascular endothelium.

Authors:  J R Starkey; H D Liggitt; W Jones; H L Hosick
Journal:  Int J Cancer       Date:  1984-10-15       Impact factor: 7.396

9.  Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis.

Authors:  Eric Camerer; Aisha A Qazi; Daniel N Duong; Ivo Cornelissen; Rommel Advincula; Shaun R Coughlin
Journal:  Blood       Date:  2004-03-18       Impact factor: 22.113

10.  Quantification of cellular volume and sub-cellular density fluctuations: comparison of normal peripheral blood cells and circulating tumor cells identified in a breast cancer patient.

Authors:  Kevin G Phillips; Anand Kolatkar; Kathleen J Rees; Rachel Rigg; Dena Marrinucci; Madelyn Luttgen; Kelly Bethel; Peter Kuhn; Owen J T McCarty
Journal:  Front Oncol       Date:  2012-08-09       Impact factor: 6.244

View more
  4 in total

1.  The role of coagulation and platelets in colon cancer-associated thrombosis.

Authors:  Annachiara Mitrugno; Samuel Tassi Yunga; Joanna L Sylman; Jevgenia Zilberman-Rudenko; Toshiaki Shirai; Jessica F Hebert; Robert Kayton; Ying Zhang; Xiaolin Nan; Joseph J Shatzel; Sadik Esener; Matthew T Duvernay; Heidi E Hamm; András Gruber; Craig D Williams; Yumie Takata; Randall Armstrong; Terry K Morgan; Owen J T McCarty
Journal:  Am J Physiol Cell Physiol       Date:  2018-11-21       Impact factor: 4.249

2.  Aspirin therapy reduces the ability of platelets to promote colon and pancreatic cancer cell proliferation: Implications for the oncoprotein c-MYC.

Authors:  Annachiara Mitrugno; Joanna L Sylman; Anh T P Ngo; Jiaqing Pang; Rosalie C Sears; Craig D Williams; Owen J T McCarty
Journal:  Am J Physiol Cell Physiol       Date:  2016-11-30       Impact factor: 4.249

Review 3.  Physical biology in cancer. 2. The physical biology of circulating tumor cells.

Authors:  Kevin G Phillips; Peter Kuhn; Owen J T McCarty
Journal:  Am J Physiol Cell Physiol       Date:  2013-10-16       Impact factor: 4.249

Review 4.  Advances in antitumor effects of NSAIDs.

Authors:  Zhen Zhang; Fulin Chen; Lijun Shang
Journal:  Cancer Manag Res       Date:  2018-10-15       Impact factor: 3.989

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.